or Try an Advanced Search...

    Technical Analysis for SZLS - Stagezero Life Sciences Ltd.

    Grade Last Price % Change Price Change
    F 0.040 0.00% 0.000
    SZLS closed unchanged on Monday, April 8, 2024, on 3.31 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical SZLS trend table...
    Date Alert Name Type % Chg
    MACD Bearish Centerline Cross Bearish 0.00%
    Jack-in-the-Box Bearish Bearish Swing Setup 0.00%
    Volume Surge Other 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    20 DMA Resistance Bearish 0.00%
    50 DMA Resistance Bearish 0.00%
    Expansion Breakdown Bearish Swing Setup 0.00%
    Volume Surge Other 0.00%
    Older End-of-Day Signals for SZLS ...

       Recent Intraday Alerts

    Alert Time
    No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock.
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    SZLS Chart by TradingView
    Basic chart:

    Profile

    StageZero Life Sciences Inc., formerly GeneNews Ltd, is a Canada-based company focused on developing and commercializing molecular diagnostic tests for early detection of cancer. It has developed Sentinel Principle platform technology, which determines biomarkers from whole blood. In additional, the Company offers ColonSentry product, it is a blood test to determine an individual’s current risk for having colorectal cancer. It is developing cancer testing kit Aristotle, which is a multi-cancer panel for simultaneously screening for 10 cancers from a single sample of blood. The Company is also focused on testing Aristotle application on other disease conditions including neurology, gastroenterology, cardiology, and autoimmune disorders.
    Classification
    Sector: Healthcare
    Industry: Diagnostics & Research
    Keywords: Mines Medicine Biotechnology Disease Science Cancer RTT Life Sciences Clinical Medicine Cancers Disorders Cell Biology Neurology Biomarker Cardiology Diagnostic Tests

    Is SZLS a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 0.15
    52 Week Low 0.035
    Average Volume 89,058
    200-Day Moving Average 0.054
    50-Day Moving Average 0.044
    20-Day Moving Average 0.045
    10-Day Moving Average 0.046
    Average True Range 0.004
    RSI (14) 45.36
    ADX 12.34
    +DI 36.276
    -DI 30.710
    Chandelier Exit (Long, 3 ATRs) 0.044
    Chandelier Exit (Short, 3 ATRs) 0.051
    Upper Bollinger Bands 0.052
    Lower Bollinger Band 0.037
    Percent B (%b) 0.21
    BandWidth 34.607
    MACD Line 0.000
    MACD Signal Line 0.001
    MACD Histogram -0.0008
    Fundamentals Value
    Market Cap 2.01 Million
    Num Shares 50.2 Million
    EPS -0.05
    Price-to-Earnings (P/E) Ratio -0.89
    Price-to-Sales 9.88
    Price-to-Book 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.040
    Resistance 3 (R3) 0.040 0.040 0.040
    Resistance 2 (R2) 0.040 0.040 0.040 0.040
    Resistance 1 (R1) 0.040 0.040 0.040 0.040 0.040
    Pivot Point 0.040 0.040 0.040 0.040 0.040
    Support 1 (S1) 0.040 0.040 0.040 0.040 0.040
    Support 2 (S2) 0.040 0.040 0.040 0.040
    Support 3 (S3) 0.040 0.040 0.040
    Support 4 (S4) 0.040